Plant ecdysteroid supplement
Turkesterone
Turkesterone, tested in the one crossover study of 11 men that was identified, did not significantly change IGF-1 or resting metabolic rate against placebo after single oral doses.1
Turkesterone after one dose: 50% at ~8 h, 25% at 16 h, 12.5% at 24 h.
Drawn from the half-life in the app's model, ~8 h. The model's figures
- Compound
- Turkesterone
- Symbol
- TRK
- Family
- Supplements
- Parts
- 8
- References
- 6
- Checked
- Last reviewed . Sources are listed below.
Overview
Values from the Milligram app's model.
- Half-life
- ~8 h
- Bioavailability
- 10%
- Typical dose
- 250–500 mg/day
- Route
- Oral
- Time to peak
- ~2 h
Sources in this part
Turkesterone is a naturally occurring plant steroid of the phytoecdysteroid group, which the authors of the one human study call "touted" for medicinal, pharmacological and biological properties.1 In supplements it is derived from the plant Ajuga turkestanica, according to a 2024 review by Todorova and colleagues at Medical University-Plovdiv.2 The app grades the evidence as anecdotal, and the review states that "Studies on the benefits of 20HE, turkesterone, and extracts from these plants are limited".2
How it works
Sources in this part
Harris and colleagues write that phytoecdysteroids "do not bind to cytosolic steroid receptors" and that their mechanisms of action "are not fully understood".1 They describe turkesterone as "postulated to have a signaling effect via membrane-bound estrogen receptor beta" binding.1 Among the animal findings in the review, sexually immature male rats given turkesterone orally at 5 mg/kg showed significant increases in body weight "comparable in anabolic effect to nerobol", which was given at 10 mg/kg; this is a result in rats and not shown in people.2
Human studies
| Study and year | Design | People | Dose and length | Main result |
|---|---|---|---|---|
| Harris and colleagues, Muscles, 2024 (turkesterone)1 | Randomised, single-blinded, placebo-controlled crossover; funded by university and ACSM chapter grants | 11 healthy, recreationally active males aged 18 to 35 | Single doses of 1000 mg or 2000 mg of a turkesterone supplement, or 2000 mg cellulose placebo, at least 7 days apart | No significant condition, time or interaction effects for serum IGF-1, resting metabolic rate or substrate use; none of the participants reported gastrointestinal symptoms |
| Isenmann and colleagues, Archives of Toxicology, 2019 (ecdysterone, not turkesterone)3 | Controlled trial of ecdysterone-containing supplements; grant from the World Anti-Doping Agency | 46 young men | Different doses of ecdysterone, 10 weeks of strength training | Higher muscle mass gain and one-repetition bench press gain in dosed participants; no increase in liver or kidney toxicity biomarkers |
| Dioh and colleagues, J Cachexia Sarcopenia Muscle, 2023 (20-hydroxyecdysone as BIO101, not turkesterone)4 | Phase 1 single and multiple ascending dose; authors are employees or former employees of the sponsor, Biophytis | 16 young and 8 older adults (single dose), 10 older adults (14 days) | 100 to 1400 mg single oral doses; 350 mg once or twice daily or 450 mg twice daily for 14 days | Mean half-life 2.4 to 4.9 h; "only mild to moderate adverse events", with adverse events more frequent at higher doses in the 14-day part (at least one in 2 of 8, 7 of 8 and 8 of 8 participants on 350 mg daily, 350 mg twice daily and 450 mg twice daily; 3 of 6 on placebo), moderate events in 2 participants on 450 mg twice daily, and no deaths, serious adverse events or discontinuations for adverse events |
| Ambrosio and colleagues, Metabolites, 2021 (ecdysterone, not turkesterone)5 | Single-dose urinary pharmacokinetics | 12 volunteers | One oral dose of 50 mg of pure ecdysterone | Urinary half-life of about 3 h; mean cumulative urinary excretion of ecdysterone 18% (SD 13%) of the dose |
Deeper analysis: Harris and colleagues, 2024
Harris and colleagues (Baylor University and co-authors) took blood for serum IGF-1 before and 1, 3 and 24 hours after each dose, and assessed resting metabolic rate over a 3 hour period after each dose.1 IGF-1 at 3 hours was 135.3 ± 53.7 and 147.9 ± 42.6 ng/mL after 1000 and 2000 mg against 72.9 ± 33.3 on placebo, but the authors report no significant condition effect and describe the rise as "non-significant".1 Their conclusion reads that neither dose "was able to significantly increase RMR" and that doses up to 2000 mg were "well tolerated" in this acute setting.1 Stated limitations: the acute design "cannot be sensibly extrapolated to longitudinal outcomes", and "diet was not standardized".1 They also call for "larger sample sizes" and describe theirs as "the first human investigation on turkesterone supplementation".1 They add that their power analyses "were predicated on other PE", that is, other phytoecdysteroids.1 Funding came from "the Baylor University Health, Human Performance, and Recreation Department" and a Texas Chapter ACSM award, and the authors declare no conflicts of interest.1
The app's typical dose is 250–500 mg/day; the authors chose 1000 and 2000 mg single doses "as most manufacturers recommend 1000 mg/day while suggesting to not exceed 2000 mg/day".1
What is not known
Sources in this part
The app lists a half-life of about 8 hours and a bioavailability of 10%; Harris and colleagues state that "the half-life of turkesterone is not fully understood" and that it is purported to resemble ecdysterone's "between 4 and 9 h".1 For ecdysterone itself, measured half-lives were about 3 h in urine (Ambrosio) and 2.4 to 4.9 h in plasma (Dioh), shorter than the app's figure for turkesterone.5,4 No turkesterone plasma half-life, bioavailability or time to peak was identified in the sources read; the 10% that Harris and colleagues mention is the usual content of turkesterone in products, not a bioavailability.1 No controlled trial of turkesterone with training, repeated dosing or hormone measures other than IGF-1 was identified in PubMed or ClinicalTrials.gov.
Frequently asked questions
Sources in this part
What is turkesterone?
Turkesterone is a naturally occurring plant steroid.1
What is the half-life of turkesterone?
What is the bioavailability of turkesterone?
Does turkesterone raise IGF-1?
In the crossover study of 11 men, turkesterone did not significantly change serum IGF-1 against placebo.1
Does turkesterone bind androgen receptors?
Is turkesterone banned by WADA?
Turkesterone does not appear by name in the WADA 2026 Prohibited List text read for this review.6 The list's category S1.2 is introduced as "Including, but not limited to"; the 2026 list text read does not name ecdysterone, a related compound, which Ambrosio and colleagues wrote in 2021 "has been included in the Monitoring Program of the World Anti-Doping Agency (WADA)" since 2020.6,5
Guides, tools and comparisons
References
- Harris DR, et al. The Effects of Multiple Acute Turkesterone Doses on Indirect Measures of Hypertrophy and Metabolic Measures: A Preliminary Investigation. Muscles 2024. PMID 40757520
- Todorova V, et al. Ecdysterone and Turkesterone-Compounds with Prominent Potential in Sport and Healthy Nutrition. Nutrients 2024. PMID 38732627
- Isenmann E, et al. Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans. Arch Toxicol 2019. PMID 31123801
- Dioh W, et al. A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults. J Cachexia Sarcopenia Muscle 2023. PMID 37057316
- Ambrosio G, et al. Urinary Elimination of Ecdysterone and Its Metabolites Following a Single-Dose Administration in Humans. Metabolites 2021. PMID 34207569
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2026. WADA list